China Animal Health 0940

China Animal Health 0940

Postby millionairemind » Wed Aug 06, 2008 2:40 pm

China Animal Healthcare Posts 63.4% Revenue Surge in 1H08

China Animal Healthcare’s revenue for 1H08 increased 63.4% from Rmb103.8m in 1H07 to Rmb169.6m in 1H08. Average selling prices have not fluctuated significantly period-on-period, while demand for the Group’s products has continued to experience strong growth in 2008 as usage of animal drugs has increased across China.

The cost of sales of the Group constituted approximately 24.9% and 23.6% of its revenue in 1H08 and 1H07 respectively.

The main components of its cost of sales include the cost of raw materials and there were no significant increases in the prices of the raw materials in 2Q08.

In line with the sales increase, gross profit surged 60.5% from Rmb79.3m in 1H07 to Rmb127.3m in 1H08.

Source: Business Times
"If a speculator is correct half of the time, he is hitting a good average. Even being right 3 or 4 times out of 10 should yield a person a fortune if he has the sense to cut his losses quickly on the ventures where he has been wrong" - Bernard Baruch

Disclaimer - The author may at times own some of the stocks mentioned in this forum. All discussions are NOT to be construed as buy/sell recommendations. Readers are advised to do their own research and analysis.
User avatar
millionairemind
Big Boss
 
Posts: 8183
Joined: Wed May 07, 2008 8:50 am
Location: The Matrix

Re: China Animal Healthcare

Postby winston » Tue Jan 12, 2010 11:29 am

Not vested.

DJ MARKET TALK: CIMB Starts China Animal Healthcare At Buy

0259 GMT [Dow Jones] STOCK CALL: CIMB starts China Animal Healthcare (EP4.SG) at Buy with S$0.44 target price, based on 9X FY11 P/E. Says share price offers excellent value, trading at 6.7X FY10 P/E vs estimated 3-year earnings CAGR of 36.9%.

Adds acquisition strategy will drive animal drug maker's earnings growth; "acquisition opportunities within the biological drugs segment remain the group's primary focus. The group is also close to securing 2 more other mandatory vaccine production licences".

Notes company has distribution network spanning 28 provinces, municipalities, autonomous regions in China, supported by 4 regional offices. Says most animal drug makers with lesser control over distribution will suffer as China could eventually open up distribution sector to foreign players.

Tips company as candidate for dual listing in HK. Shares flat at S$0.27


Source: Dow Jones Newswire
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118539
Joined: Wed May 07, 2008 9:28 am

Re: China Animal Healthcare

Postby winston » Thu Jan 21, 2010 5:52 pm

Not vested. From DBS:-

China Animal Healthcare has received approval to produce blue-ear disease vaccine. DBS Research has
revised earnings up by 25% and 56% for FY10 and FY11, respectively, by factoring in the blue-ear vaccine
contribution and lowering opex assumptions.

Plans for dual-listing could be a potential catalyst. Reiterate Buy, TP raised to S$0.40 (Prev S$ 0.29).
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118539
Joined: Wed May 07, 2008 9:28 am

Re: China Animal Healthcare

Postby millionairemind » Mon Feb 08, 2010 6:29 pm

February 8, 2010, 4.08 pm (Singapore time)

China Animal's unit to buy pig vaccine company for S$43.44 mln

By ANGELA TAN

China Animal Healthcare Ltd said its subsidiary, Shenzhou Pagina-kang Technology Co Ltd has agreed to buy Jianxiang Hemu from its four shareholders for a total of RMB210 million (S$43.44 million).

The sale price took into consideration, amongst other factors, the potential of the vaccine for porcine reproductive respiratory syndrome developed by Jianxiang.

China Animal said the board feels the acquisition is in the best interest of the group (?? WHich group?? :P) and will further expand the range of its biological animal drug products, which include vaccines for swine fever and other livestock vaccines for immunisation against common diseases and viruses.
"If a speculator is correct half of the time, he is hitting a good average. Even being right 3 or 4 times out of 10 should yield a person a fortune if he has the sense to cut his losses quickly on the ventures where he has been wrong" - Bernard Baruch

Disclaimer - The author may at times own some of the stocks mentioned in this forum. All discussions are NOT to be construed as buy/sell recommendations. Readers are advised to do their own research and analysis.
User avatar
millionairemind
Big Boss
 
Posts: 8183
Joined: Wed May 07, 2008 8:50 am
Location: The Matrix

Re: China Animal Healthcare

Postby winston » Tue Feb 09, 2010 3:16 pm

Not vested.

DJ MARKET TALK: DBS Vickers Cuts China Animal Target To S$0.33


0645 GMT [Dow Jones] STOCK CALL: DBS Vickers cuts China Animal Healthcare (EP4.SG) target price to S$0.33 from S$0.40, based on 12X FY10 P/E, after lowering earnings forecasts for FY10 by 18%, for FY11 by 7% to factor in delay in production of vaccine for hand-foot-mouth disease.

Notes animal drugs maker expects to obtain production licence for vaccine by March, and accompanying product code for sales around mid-2010, meaning it won't be able to take part in government's February bidding exercise to award production licence; "(it) will only be able to take part in the August 2010 bidding season."

Still, keeps Buy call, noting stock backed by 31% earnings CAGR over FY09-11, trades at 8.6X FY10 P/E vs 25X FY10 P/E for Chinese peers. Shares off 2.1% at S$0.235. (FKH)

Source: Dow Jones Newswire
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118539
Joined: Wed May 07, 2008 9:28 am

Re: China Animal Healthcare

Postby millionairemind » Mon Apr 12, 2010 7:05 pm

Another one??? :roll: :roll: :roll: :roll:

April 12, 2010, 6.49 pm (Singapore time)

China Animal plans dual listing in HK

By LYNETTE KHOO

China Animal Healthcare is the latest to join on the bandwagon of dual listings among S-chips here.

The company said it plans to seek a dual primary listing on the Hong Kong Stock Exchange, together with a public offering of new shares.

'The directors are of the view that it is desirable and beneficial for the Company to have dual primary listing status in both Singapore and Hong Kong so that the company can tap readily into two of Asia's most dynamic equity markets when the opportunity arises,' the group said on Monday.

'Furthermore, the HK dual listing will widen the investor base of the company so that the company may benefit from its exposure to a bigger range of private and institutional investors, and is expected to increase share trading liquidity.'

China Animal said it has commenced preparatory work for the plan and plans to appoint its sponsor as well as other professional advisers very soon.
"If a speculator is correct half of the time, he is hitting a good average. Even being right 3 or 4 times out of 10 should yield a person a fortune if he has the sense to cut his losses quickly on the ventures where he has been wrong" - Bernard Baruch

Disclaimer - The author may at times own some of the stocks mentioned in this forum. All discussions are NOT to be construed as buy/sell recommendations. Readers are advised to do their own research and analysis.
User avatar
millionairemind
Big Boss
 
Posts: 8183
Joined: Wed May 07, 2008 8:50 am
Location: The Matrix

Re: China Animal Healthcare

Postby Musicwhiz » Mon Apr 12, 2010 7:36 pm

Makes you wonder why they don't spend more time building the business in order to "enhance shareholder's value", rather than engaging in all this hullabaloo to dual-list and "achieve higher valuations". :lol:
Please visit my value investing blog at http://sgmusicwhiz.blogspot.com
User avatar
Musicwhiz
Boss' Right Hand Person
 
Posts: 1257
Joined: Sat May 17, 2008 2:02 am

Re: China Animal Healthcare

Postby millionairemind » Mon Apr 12, 2010 7:51 pm

Musicwhiz wrote:Makes you wonder why they don't spend more time building the business in order to "enhance shareholder's value", rather than engaging in all this hullabaloo to dual-list and "achieve higher valuations". :lol:


Or rather, Y do they deserve such low valuations in the first place. :lol: :lol:

With CEOs running away with the money, truckloads of account books disappearing, defaulting on bonds etc.. etc.... :? :?

I just heard a rumor from a real estate friend. One of the CEO of a listed Chinese company whose shares got suspended had bot 2 Good Class Bungalows in Singapore recently... :lol:
"If a speculator is correct half of the time, he is hitting a good average. Even being right 3 or 4 times out of 10 should yield a person a fortune if he has the sense to cut his losses quickly on the ventures where he has been wrong" - Bernard Baruch

Disclaimer - The author may at times own some of the stocks mentioned in this forum. All discussions are NOT to be construed as buy/sell recommendations. Readers are advised to do their own research and analysis.
User avatar
millionairemind
Big Boss
 
Posts: 8183
Joined: Wed May 07, 2008 8:50 am
Location: The Matrix

Re: China Animal Healthcare

Postby Musicwhiz » Mon Apr 12, 2010 10:53 pm

OK MM, that's not surprising. Hoodwinked and fooled. Oh well. ;)
Please visit my value investing blog at http://sgmusicwhiz.blogspot.com
User avatar
Musicwhiz
Boss' Right Hand Person
 
Posts: 1257
Joined: Sat May 17, 2008 2:02 am

Re: China Animal Healthcare

Postby winston » Tue Jul 06, 2010 4:55 am

Not vested. From OCBC:-

A company linked to the Blackstone Group is investing about US$45m into China Animal Healthcare
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118539
Joined: Wed May 07, 2008 9:28 am

Next

Return to C

Who is online

Users browsing this forum: No registered users and 8 guests

cron